Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Decreases By 89.5%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant decline in short interest in February. As of February 15th, there was short interest totalling 400 shares, a decline of 89.5% from the January 31st total of 3,800 shares. Based on an average trading volume of 5,400 shares, the short-interest ratio is currently 0.1 days.

Fidelity Disruptive Medicine ETF Stock Performance

Fidelity Disruptive Medicine ETF stock traded down $0.47 during midday trading on Thursday, hitting $25.00. 6,042 shares of the company’s stock were exchanged, compared to its average volume of 5,551. The firm has a 50-day moving average of $25.63 and a two-hundred day moving average of $25.79. Fidelity Disruptive Medicine ETF has a 12 month low of $23.32 and a 12 month high of $26.79. The company has a market cap of $52.49 million, a PE ratio of 43.85 and a beta of 0.94.

Fidelity Disruptive Medicine ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Friday, December 20th were issued a $0.112 dividend. The ex-dividend date was Friday, December 20th. This is an increase from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00. This represents a $0.45 dividend on an annualized basis and a dividend yield of 1.79%.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC lifted its stake in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 200.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 61,342 shares of the company’s stock after purchasing an additional 40,924 shares during the quarter. Jane Street Group LLC owned about 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 as of its most recent SEC filing.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.